1) cyclosporine A
环孢菌素A
1.
Preparation of self-microemulsifying semi-solid matrix hard capsules of cyclosporine A;
环孢菌素A自乳化半固体骨架胶囊的制备
2.
In Vitro study of the effect of cyclosporine A,tetrandrine and their combination on the reversion of multidrug resistance in leukemia cell line;
环孢菌素A、汉防己甲素及两者联合逆转K562/A02细胞的多药耐药
3.
General physiologically pharmcokinetics model of cyclosporine A;
环孢菌素A的生理药物动力学模型
2) cyclosporin A
环孢菌素A
1.
Clinical observation of cyclosporin A in treatment of severe ulcerative colitis;
环孢菌素A治疗重度溃疡性结肠炎的临床观察
2.
Effects of combination of Genistein with Cyclosporin A on immune response of mouse lymphocytes in vitro;
染料木黄酮与环孢菌素A联合用药对小鼠淋巴细胞体外免疫应答的影响
3.
Effect of cyclosporin A on sorcin gene expression and clinical effect in multiple myeloma patients;
环孢菌素A对多发性骨髓瘤患者Sorcin基因表达和临床疗效的影响
3) Cyclosporine
[英][,saikləu'spɔ:ri:n] [美][,saɪklə'spɔrin, -ɪn, -'spor-]
环孢菌素A
1.
Co-zaofanwan Combining With Cyclosporine A in the Treatment of Chronicaplastic Anemia;
复方皂矾丸联合环孢菌素A治疗慢性再生障碍性贫血的研究
2.
Continuous Changes of the Immune System in Diabetic Rats and Effects of Cyclosporine A on the Immune System;
糖尿病大鼠免疫系统的动态变化和环孢菌素A的干预作用
3.
Slowing progression of chronic allograft nephropathy by conversion from cyclosporine to tacrolimus
环孢菌素A代以他克莫司延缓移植肾慢性失功临床研究
4) CsA
环孢菌素A
1.
Objective To explore and compare the reliability of determining the density of Cyclosporin A(CsA) by two methods.
目的探讨两种方法测定环孢菌素A浓度结果的可靠性。
5) cyclosporine
[英][,saikləu'spɔ:ri:n] [美][,saɪklə'spɔrin, -ɪn, -'spor-]
环孢菌素
1.
Comparison between cyclosporine and glucocorticoid in treatment of oral lichen planus:a systematic review
比较环孢菌素与糖皮质激素治疗口腔扁平苔藓的系统评价
2.
Diazoxide and Cyclosporine A inhibits cultured primitive rat basal forebrain cholinergic neuron apoptosis induced by Aβ_(1-42)
二氮嗪、环孢菌素A拮抗Aβ_(1-42)致胆碱能神经元凋亡的研究
3.
OBJECTIVE To construct a population pharmacokinetic model for cyclosporine, which was constructed by NONMEM, and to adjust administration individually.
目的以环孢菌素(CSA)为模型药物,在NONMEM程序构建的群体药动学模型的基础上,通过EXCEL实现个体化给药。
6) cyclosporin
[,saikləu'spɔ:rin]
环孢菌素
1.
Investigation of Drug Resistance of Monilia to Fluconazole and 5-fluocytosine and the Synergistic Effect of Fluconazole and Cyclosporin in Vitro;
35株念珠菌药敏分析及氟康唑和环孢菌素的体外协同作用
2.
Objective To investigate the clinical effect of cyclosporin A(CsA) as a reversal agent associated with classical chemotheraphy to reverse multidrug resistance(MDR) in refractory acute leukemia(RAL).
目的:探讨环孢菌素A(CsA)作为耐药逆转剂联合化疗逆转难治性急性白血病(RAL)多药耐药(MDR)的临床疗效。
3.
Objective To observe the therapeutic effect of TCM syndrome-typing based therapy(TCM-STBT)combined with cyclosporin on myelodysplastic syndrome(MDS)and investigate the correlation of efficacy with TCM syndrome type and MDS type.
目的观察中医分型论治联合环孢菌素治疗骨髓增生异常综合征的临床疗效及中医不同证型与西医分型在疗效方面的相关性。
补充资料：环孢菌素A
分子式：
CAS号：
性质：一种强效免疫抑制剂。由球枝菌Tolypocladium inflatum、多孔木霉Tricoderma polysporum和茄病镰刀霉Fusarium solani发酵所产生的十一环肽，不溶于水。可逆地抑制有免疫功能的T淋巴细胞，而不损伤其他细胞，对骨髓无毒性作用。它抑制抗体的产生和移植物的排斥作用，抑制白细胞介素IL-1和IL-2的产生等，是举世公认的第三代免疫抑制剂。针状结晶，熔点148～151℃。旋光度[α]D20-244°(c=0.6，氯仿)。主要用于治疗器官和组织移植病人抑制免疫排斥反应，大大提高移植物的存活率，用于治疗自身免疫性疾病等。主要副作用是应用过程出现的肾毒性、高血压和高血脂症。由于它有微弱的抗真菌作用，因此1976年环孢菌素A是作为抗真菌抗生素而报道的。
CAS号：
性质：一种强效免疫抑制剂。由球枝菌Tolypocladium inflatum、多孔木霉Tricoderma polysporum和茄病镰刀霉Fusarium solani发酵所产生的十一环肽，不溶于水。可逆地抑制有免疫功能的T淋巴细胞，而不损伤其他细胞，对骨髓无毒性作用。它抑制抗体的产生和移植物的排斥作用，抑制白细胞介素IL-1和IL-2的产生等，是举世公认的第三代免疫抑制剂。针状结晶，熔点148～151℃。旋光度[α]D20-244°(c=0.6，氯仿)。主要用于治疗器官和组织移植病人抑制免疫排斥反应，大大提高移植物的存活率，用于治疗自身免疫性疾病等。主要副作用是应用过程出现的肾毒性、高血压和高血脂症。由于它有微弱的抗真菌作用，因此1976年环孢菌素A是作为抗真菌抗生素而报道的。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条